0001193125-25-226749.txt : 20251001 0001193125-25-226749.hdr.sgml : 20251001 20251001160522 ACCESSION NUMBER: 0001193125-25-226749 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250926 ITEM INFORMATION: Other Events FILED AS OF DATE: 20251001 DATE AS OF CHANGE: 20251001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIODESIX INC CENTRAL INDEX KEY: 0001439725 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 203986492 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39659 FILM NUMBER: 251364653 BUSINESS ADDRESS: STREET 1: 919 WEST DILLON ROAD CITY: LOUISVILLE STATE: CO ZIP: 80027 BUSINESS PHONE: 303-417-0500 MAIL ADDRESS: STREET 1: 919 WEST DILLON ROAD CITY: LOUISVILLE STATE: CO ZIP: 80027 8-K 1 d20952d8k.htm 8-K 8-K
BIODESIX INC false 0001439725 0001439725 2025-09-26 2025-09-26
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

September 26, 2025

Date of Report (Date of earliest event reported)

 

 

Biodesix, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39659   20-3986492

(State or other jurisdiction

of incorporation)

  

(Commission

File No.)

  

(IRS Employer

Identification No.)

 

919 West Dillon Rd.  
Louisville, CO   80027
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (303) 417-0500

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of Each Class

  

Trading
Symbol(s)

  

Name of Each Exchange

on Which Registered

Common Stock, par value $0.001 per share   BDSX   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

Item 8.01.

Other Events.

On September 26, 2025, Biodesix, Inc., a Delaware corporation (the “Company”) received a letter from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”) for continued listing on The Nasdaq Global Market.

As previously disclosed, on March 24, 2025, the Company received a letter from Nasdaq, notifying the Company that it was not in compliance with the Minimum Bid Price Requirement because the Company’s common stock, par value $0.001 (the “Common Stock”), had closed below the $1.00 per share minimum for 30 consecutive business days. To regain compliance with the Minimum Bid Price Requirement, the Common Stock was required to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days.

In its letter dated September 26, 2025, Nasdaq indicated the Company has regained compliance with the Minimum Bid Price Requirement, and the matter is now closed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: October 1, 2025   BIODESIX, INC.

 

     By:  

/s/ Robin Harper Cowie

    Name:   Robin Harper Cowie
    Title:   Chief Financial Officer
 EX-101.SCH 2 bdsx-20250926.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 bdsx-20250926_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 4 bdsx-20250926_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.25.2
Document and Entity Information
Sep. 26, 2025
Cover [Abstract]  
Entity Registrant Name BIODESIX INC
Amendment Flag false
Entity Central Index Key 0001439725
Document Type 8-K
Document Period End Date Sep. 26, 2025
Entity Incorporation State Country Code DE
Entity File Number 001-39659
Entity Tax Identification Number 20-3986492
Entity Address, Address Line One 919 West Dillon Rd.
Entity Address, City or Town Louisville
Entity Address, State or Province CO
Entity Address, Postal Zip Code 80027
City Area Code (303)
Local Phone Number 417-0500
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001 per share
Trading Symbol BDSX
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.2 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports bdsx-20250926.xsd bdsx-20250926_lab.xml bdsx-20250926_pre.xml d20952d8k.htm http://xbrl.sec.gov/dei/2025 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d20952d8k.htm": { "nsprefix": "bdsx", "nsuri": "http://biodesix.com/20250926", "dts": { "schema": { "local": [ "bdsx-20250926.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/naics/2025/naics-2025.xsd" ] }, "labelLink": { "local": [ "bdsx-20250926_lab.xml" ] }, "presentationLink": { "local": [ "bdsx-20250926_pre.xml" ] }, "inline": { "local": [ "d20952d8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2025": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2025": 23 }, "report": { "R1": { "role": "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2025-09-26_to_2025-09-26", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d20952d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2025-09-26_to_2025-09-26", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d20952d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityExTransitionPeriod", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementTenderOffer", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SolicitingMaterial", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "WrittenCommunications", "presentation": [ "http://biodesix.com//20250926/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001193125-25-226749-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-25-226749-xbrl.zip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d20952d8k_htm.xml IDEA: XBRL DOCUMENT 0001439725 2025-09-26 2025-09-26 BIODESIX INC false 0001439725 8-K 2025-09-26 DE 001-39659 20-3986492 919 West Dillon Rd. Louisville CO 80027 (303) 417-0500 false false false false Common Stock, par value $0.001 per share BDSX NASDAQ true false